JP2020501521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020501521A5 JP2020501521A5 JP2019524202A JP2019524202A JP2020501521A5 JP 2020501521 A5 JP2020501521 A5 JP 2020501521A5 JP 2019524202 A JP2019524202 A JP 2019524202A JP 2019524202 A JP2019524202 A JP 2019524202A JP 2020501521 A5 JP2020501521 A5 JP 2020501521A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- variant
- linked
- derivative
- isolated protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016904572A AU2016904572A0 (en) | 2016-11-09 | Subtilase cytotoxin b subunit mutant | |
| AU2016904572 | 2016-11-09 | ||
| PCT/AU2017/051230 WO2018085888A1 (en) | 2016-11-09 | 2017-11-09 | Subtilase cytotoxin b subunit mutant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020501521A JP2020501521A (ja) | 2020-01-23 |
| JP2020501521A5 true JP2020501521A5 (enExample) | 2020-12-17 |
| JP7123921B2 JP7123921B2 (ja) | 2022-08-23 |
Family
ID=62109062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524202A Active JP7123921B2 (ja) | 2016-11-09 | 2017-11-09 | サブチラーゼサイトトキシンｂサブユニット変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11371033B2 (enExample) |
| EP (1) | EP3538544B1 (enExample) |
| JP (1) | JP7123921B2 (enExample) |
| KR (1) | KR102703633B1 (enExample) |
| CN (1) | CN110402251A (enExample) |
| AU (1) | AU2017358401B2 (enExample) |
| CA (1) | CA3044303A1 (enExample) |
| ES (1) | ES2983352T3 (enExample) |
| WO (1) | WO2018085888A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112760305B (zh) * | 2021-01-25 | 2022-04-29 | 浙江工业大学 | 一种栖热腔菌磷酸酶突变体及其应用 |
| JP2024517893A (ja) * | 2021-05-06 | 2024-04-23 | イノヴィック・インコーポレイテッド | 腫瘍由来細胞外小胞に関する方法 |
| US20240239846A1 (en) * | 2021-05-14 | 2024-07-18 | The University Of Adelaide | Methods of analysing a sample |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO007396A0 (en) | 1996-05-24 | 1996-06-20 | Csl Limited | Ebv ctl epitopes |
| AUPO784197A0 (en) | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
| DE60203491D1 (de) * | 2002-08-02 | 2005-05-04 | Inst Curie Paris | Shiga-Toxin-Untereinheit B als Vektor zur Diagnose von Tumoren und zur Arzneimittelverabreichung an GB3-exprimierenden Tumoren |
| CA2465009C (en) * | 2003-12-22 | 2015-02-03 | Adelaide Research & Innovation Pty Ltd. | Cytotoxin with a subtilase domain |
| EP2667898A1 (en) * | 2011-01-26 | 2013-12-04 | Cenix Bioscience GmbH | Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
-
2017
- 2017-11-09 CN CN201780082403.7A patent/CN110402251A/zh active Pending
- 2017-11-09 JP JP2019524202A patent/JP7123921B2/ja active Active
- 2017-11-09 CA CA3044303A patent/CA3044303A1/en active Pending
- 2017-11-09 KR KR1020197014900A patent/KR102703633B1/ko active Active
- 2017-11-09 US US16/348,732 patent/US11371033B2/en active Active
- 2017-11-09 ES ES17870370T patent/ES2983352T3/es active Active
- 2017-11-09 EP EP17870370.8A patent/EP3538544B1/en active Active
- 2017-11-09 WO PCT/AU2017/051230 patent/WO2018085888A1/en not_active Ceased
- 2017-11-09 AU AU2017358401A patent/AU2017358401B2/en active Active
-
2022
- 2022-05-27 US US17/827,072 patent/US20220372459A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7573437B2 (ja) | 膜タンパク質を使用する治療用エクソソームの調製 | |
| JP2024037858A (ja) | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| TWI599367B (zh) | Ｈｌａ-ａ*１１０１限制性ｗｔ１胜肽之用途 | |
| CN109803981B (zh) | 用于头颈鳞状细胞癌和其他癌症免疫治疗的新型肽和支架 | |
| JP2018521641A (ja) | 卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチドの組み合わせ | |
| JP2016524592A5 (enExample) | ||
| JP2016519932A5 (enExample) | ||
| US10745478B2 (en) | Antibody fusion protein and related compositions for targeting cancer | |
| EP2290104A3 (de) | Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie | |
| RU2015146419A (ru) | Выделение терапевтических доменов vnar, специфичных по отношению к мишени icosl | |
| JP2017536337A5 (enExample) | ||
| HK1210713A1 (en) | Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof | |
| CN118085109A (zh) | 免疫调节化合物 | |
| JP2020501521A5 (enExample) | ||
| JP2015057387A (ja) | クロスベータ構造体でのタンパク質の凝集の標的化誘導 | |
| JP2008543961A5 (enExample) | ||
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| US20190321481A1 (en) | Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms | |
| CN107266552B (zh) | 源自于prame的肿瘤抗原短肽 | |
| KR20240161969A (ko) | 종양 항원, 종양 항원 kras, tpx2 또는 aurka을 포함하는 화합물 및 그 용도 | |
| CN108250289B (zh) | 源自于mage b6的肿瘤抗原短肽 | |
| Mohammed et al. | Protein Engineering and Drug Discovery: Importance, Methodologies, Challenges, and Prospects. Biomolecules 2025, 15, 1628 | |
| Smyrniotou et al. | 2-Oxoamides based on dipeptides and pseudodipeptides as inhibitors of Ca2+-independent phospholipase A2 | |
| Zhang et al. | Synergetic protein factors that improve rhGM-CSF absorption via an oral route exist in silkworm pupae | |
| CN108203459A (zh) | 源自于prame的肿瘤抗原短肽 |